Cite
HARVARD Citation
Besson, C. et al. (n.d.). P14.125 Retrospective analysis of long-term response to bevacizumab in combination with irinotecan for recurrent glioblastoma: identification of prognostic factors. Neuro-oncology. p. iii98. [Online].